AstraZeneca PLC (NASDAQ:AZN)
| 65.26 BATS BZX Real-Time Price As of 1:36pm ET |  -0.82 / -1.24%Today’s Change | 53.63 Today|||52-Week Range 71.70 | +12.03% Year-to-Date |
Latest AZN News | Press Releases
Today’s Trading
| Previous close | 66.08 |
| Today’s open | 64.11 |
| Day’s range | 64.08 - 65.36 |
| Volume | 261,427 |
| Average volume (3 months) | 7,169,116 |
| Market cap | $207.3B |
Data as of 1:36pm ET, 07/01/2022
Growth & Valuation
| Earnings growth (last year) | -96.76% |
| Earnings growth (this year) | +26.14% |
| Earnings growth (next 5 years) | +17.33% |
| Revenue growth (last year) | +37.11% |
| P/E ratio | NM |
| Price/Sales | 4.39 |
| Price/Book | 5.28 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVONovo Nordisk | -0.98 | -0.88% |
| NVSNovartis | -0.93 | -1.10% |
| MRKMerck | +0.46 | +0.50% |
| BMYBristol-Myers Squibb | -0.93 | -1.21% |
Data as of 1:36pm ET, 07/01/2022
Financials
| Next reporting date | July 29, 2022 |
| EPS forecast (this quarter) | $0.81 |
| Annual revenue (last year) | $37.8B |
| Annual profit (last year) | $112.0M |
| Net profit margin | 0.30% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Cambridgeshire |
Forecasts
